Pharmaron Beijing Market Cap

Pharmaron Beijing has a market cap or net worth of 44.56 billion as of March 28, 2025. Its market cap has increased by 18.48% in one year.

Market Cap

44.56B

Enterprise Value

48.07B

Revenue

12.28B

Ranking

n/a

PE Ratio

26.86

Stock Price

27.16

Market Cap Chart

Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 44.56B, an increase of 515.52%. That is a compound annual growth rate of 34.27%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	44.56B	6.48%
Dec 31, 2024	41.85B	-11.66%
Dec 29, 2023	47.37B	-38.44%
Dec 30, 2022	76.95B	-27.67%
Dec 31, 2021	106.40B	12.84%
Dec 31, 2020	94.29B	140.25%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	309.09B
Shenzhen Mindray Bio-Medical Electronics	287.93B
WuXi AppTec	195.47B
Aier Eye Hospital Group	125.42B
Zhangzhou Pientzehuang Pharmaceutical.,	122.96B
Yunnan Baiyao Group Co.,Ltd	100.20B
Shanghai United Imaging Healthcare	100.16B
Sichuan Biokin Pharmaceutical	95.03B

Market Cap Rankings